These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 4064047)

  • 1. Urinary excretion of modified nucleosides in patients with acquired immune deficiency syndrome (AIDS) and individuals at high risk of AIDS.
    Fischbein A; Sharma OK; Valciukas JA; Bekesi JG; Buschman F; Apell G; Kohn M; Boesch RR; Teirstein A; Selikoff IJ
    Cancer Detect Prev; 1985; 8(1-2):271-7. PubMed ID: 4064047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified nucleosides in patients with acquired immune deficiency syndrome (AIDS) and individuals at high risk of AIDS: correlations with lymphadenomegaly and immunological parameters.
    Fischbein A; Bekesi JG; Solomon S; Borek E; Sharma OK
    Cancer Detect Prev Suppl; 1987; 1():589-96. PubMed ID: 3500786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered excretion of modified nucleosides and beta-aminoisobutyric acid in subjects with acquired immunodeficiency syndrome or at risk for acquired immunodeficiency syndrome.
    Borek E; Sharma OK; Buschman FL; Cohn DL; Penley KA; Judson FN; Dobozin BS; Horsburgh CR; Kirkpatrick CH
    Cancer Res; 1986 May; 46(5):2557-61. PubMed ID: 3008993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis, identification and determination of urinary modified nucleosides of cancer and AIDS patients.
    Nakano K; Yasaka T; Nakao T; Schram KH; Hammargren WM
    Nucleic Acids Symp Ser; 1990; (22):31-2. PubMed ID: 2101906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of whole-body RNA catabolism based on the urinary modified nucleoside levels of cancer and AIDS patients.
    Nakano K; Nakao T; Schram KH; Hammargren WM
    Nucleic Acids Symp Ser; 1991; (25):125-6. PubMed ID: 1726802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary excretion of modified nucleosides in patients with malignant mesothelioma.
    Fischbein A; Sharma OK; Selikoff IJ; Borek E
    Cancer Res; 1983 Jun; 43(6):2971-4. PubMed ID: 6850607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monocyte function in the acquired immune deficiency syndrome. Defective chemotaxis.
    Smith PD; Ohura K; Masur H; Lane HC; Fauci AS; Wahl SM
    J Clin Invest; 1984 Dec; 74(6):2121-8. PubMed ID: 6511917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfer RNA breakdown products in the urine of asbestos workers.
    Fischbein A; Sharma OK; Solomon S; Buschman F; Apell G; Kohn M; Selikoff IJ; Bekesi JG; Borek E
    Cancer Detect Prev; 1984; 7(4):247-52. PubMed ID: 6488216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfusion associated AIDS in Mexico. Clinical spectrum, conditional latency distribution, and survival.
    Volkow P; Ponce de León S; Calva J; Ruiz-Palacios G; Mohar A
    Rev Invest Clin; 1993; 45(2):133-8. PubMed ID: 8337540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [AIDS and the eye].
    Grasl M; Radda T; Hutterer J
    Klin Monbl Augenheilkd; 1985 Nov; 187(5):457-9. PubMed ID: 4087813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV infection and AIDS.
    Lloyd A
    P N G Med J; 1996 Sep; 39(3):174-80. PubMed ID: 9795558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of AIDS-related Kaposi's sarcoma in Europe over 10 years. AIDS in Europe Study Group.
    Hermans P; Lundgren J; Sommereijns B; Pedersen C; Vella S; Katlama C; Lüthy R; Pinching AJ; Gerstoft J; Pehrson P; Clumeck N
    AIDS; 1996 Jul; 10(8):911-7. PubMed ID: 8828749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kaposi's sarcoma and AIDS in Uganda: its frequency and gastrointestinal distribution.
    Ravera M; Reggiori A; Cocozza E; Andreata M; Ciantia F
    Ital J Gastroenterol; 1994 Sep; 26(7):329-33. PubMed ID: 7812024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kaposi's sarcoma and community-acquired immune deficiency syndrome.
    Abemayor E; Calcaterra TC
    Arch Otolaryngol; 1983 Aug; 109(8):536-42. PubMed ID: 6307239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of Kaposi's sarcoma and mycosis fungoides in the United States including Puerto Rico, 1973-81.
    Biggar RJ; Horm J; Fraumeni JF; Greene MH; Goedert JJ
    J Natl Cancer Inst; 1984 Jul; 73(1):89-94. PubMed ID: 6588239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [AIDS-associated Kaposi's sarcoma: 22 cases].
    Dhrif AS; Kilani B; Ammari L; Kanoun F; Tiouri H; Ben Chaaben T
    Tunis Med; 2007 Jun; 85(6):494-9. PubMed ID: 17644904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidemiology of acquired immunodeficiency syndrome malignancies.
    Goedert JJ
    Semin Oncol; 2000 Aug; 27(4):390-401. PubMed ID: 10950365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for Kaposi's sarcoma in patients with advanced human immunodeficiency virus disease treated with zidovudine. Zidovudine Epidemiology Study Group.
    Gallant JE; Moore RD; Richman DD; Keruly J; Chaisson RE
    Arch Intern Med; 1994 Mar; 154(5):566-72. PubMed ID: 8122950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer incidence in AIDS patients in Catalonia, Spain.
    Galceran J; Marcos-Gragera R; Soler M; Romaguera A; Ameijide A; Izquierdo A; Borràs J; de Sanjosé S; Casabona J
    Eur J Cancer; 2007 Apr; 43(6):1085-91. PubMed ID: 17349785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.